Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: a phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy. [electronic resource]
Producer: 20080520Description: 62 p. digitalISSN:- 1471-2407
- Administration, Oral
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Breast Neoplasms -- diagnosis
- Carcinoma, Ductal, Breast -- diagnosis
- Drug Administration Schedule
- Female
- Humans
- Letrozole
- Lymphatic Metastasis
- Mammography
- Mastectomy
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Nitriles -- administration & dosage
- Postmenopause -- metabolism
- Preoperative Care
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.